Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  118,183 results for ""Vaccines""

Your Filters

Subject : vaccines Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

In silico designed novel multi-epitope mRNA vaccines against Brucella by targeting extracellular protein BtuB and LptD.

  • Authors : Shi J; Department of Clinical Laboratory, The First Affiliated Hospital of Xinjiang Medical University, No. 393, Xinyi Road, Urumqi, 830011, Xinjiang, China.; Zhu Y

Subjects: Brucella*/Brucella*/Brucella*/genetics ; Vaccines* ; Escherichia coli Proteins*

  • Source: Scientific reports [Sci Rep] 2024 Mar 27; Vol. 14 (1), pp. 7278. Date of Electronic Publication: 2024 Mar 27.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

The Nucleocapsid Protein of SARS-CoV-2, Combined with ODN-39M, Is a Potential Component for an Intranasal Bivalent Vaccine with Broader Functionality.

  • Authors : Lobaina Y; Research Department, China-Cuba Biotechnology Joint Innovation Center (CCBJIC), Lengshuitan District, Yongzhou 425000, China.; R&D Department, Yongzhou Zhong Gu Biotechnology Co., Ltd., Yangjiaqiao Street, Lengshuitan District, Yongzhou 425000, China.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Animals SARS-CoV-2 variants

  • Source: Viruses [Viruses] 2024 Mar 08; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 08.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cross-Reactivity Assessment of Vaccine-Derived SARS-CoV-2 T Cell Responses against BA.2.86 and JN.1.

  • Authors : Sohail MS; Department of Electronic and Computer Engineering, The Hong Kong University of Science and Technology, Hong Kong SAR, China.; Ahmed SF

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Humans SARS-CoV-2 variants

  • Source: Viruses [Viruses] 2024 Mar 20; Vol. 16 (3). Date of Electronic Publication: 2024 Mar 20.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Development of membrane protein-based vaccine against lumpy skin disease virus (LSDV) using immunoinformatic tools.

  • Authors : Salauddin M; Department of Microbiology and Public Health, Khulna Agricultural University, Khulna, Bangladesh.; Kayesh MEH

Subjects: Lumpy skin disease virus* ; Vaccines*; Animals

  • Source: Veterinary medicine and science [Vet Med Sci] 2024 May; Vol. 10 (3), pp. e1438.Publisher: John Wiley & Sons Ltd Country of Publication: England NLM ID: 101678837 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Willingness to receive COVID-19 vaccines, associated factors and reasons for not taking a vaccine: a cross sectional study among persons aged 13-80 years in Wakiso, Central Uganda.

  • Authors : Daama A; Africa Medical and Behavioral Sciences Organization, Nansana, Uganda. .; Makerere University School of Public Health, Kampala, Uganda. .

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Apr 11; Vol. 24 (1), pp. 391. Date of Electronic Publication: 2024 Apr 11.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Read Online Read More Add to Saved list
×
Academic Journal

How do people with long COVID utilize COVID-19 vaccination and rehabilitation services and what are their experiences with these services? results of a qualitative study with 48 participants from Germany.

  • Authors : Schmachtenberg T; Department of General Practice, University Medical Center Göttingen, Humboldtallee 38, 37073, Göttingen, Germany. .; Department of Rheumatology and Immunology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. .

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Adult

  • Source: BMC public health [BMC Public Health] 2024 Mar 28; Vol. 24 (1), pp. 915. Date of Electronic Publication: 2024 Mar 28.Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458

Record details

Read Online Read More Add to Saved list
×
Academic Journal

A computational approach to design a multiepitope vaccine against H5N1 virus.

  • Authors : Dashti F; School of Medicine, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.; Student Research Committee, Kashan University of Medical Sciences, Kashan, Islamic Republic of Iran.

Subjects: Influenza A Virus, H5N1 Subtype*/Influenza A Virus, H5N1 Subtype*/Influenza A Virus, H5N1 Subtype*/genetics ; Vaccines*; Animals

  • Source: Virology journal [Virol J] 2024 Mar 20; Vol. 21 (1), pp. 67. Date of Electronic Publication: 2024 Mar 20.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Exploring Factors Influencing COVID-19 Vaccine Hesitancy and Refusal: A Study in Italy during the Vaccine Rollout.

  • Authors : Barazzetti A; Department of Human and Social Sciences, University of Bergamo, 24129 Bergamo, Italy.; Milesi S

Subjects: COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*

  • Source: International journal of environmental research and public health [Int J Environ Res Public Health] 2024 Mar 12; Vol. 21 (3). Date of Electronic Publication: 2024 Mar 12.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238455 Publication Model: Electronic Cited Medium: Internet ISSN: 1660-4601

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Comparative efficacy and safety of COVID-19 vaccines in phase III trials: a network meta-analysis.

  • Authors : Wu X; Medical School of Nanjing University, Nanjing, 210000, China.; Xu K

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Vaccines*; Adult

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Feb 21; Vol. 24 (1), pp. 234. Date of Electronic Publication: 2024 Feb 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Engineered EVs with pathogen proteins: promising vaccine alternatives to LNP-mRNA vaccines.

  • Authors : Zhang B; Institute of Molecular and Cellular Biology, A*STAR, 8A Biomedical Grove, Singapore, 138648, Singapore.; Paracrine Therapeutics Pte. Ltd., 10 Choa Chu Kang Grove #13-22 Sol Acres, Singapore, 688207, Singapore.

Subjects: Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/Mesenchymal Stem Cells*/metabolism ; Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/metabolism ; Exosomes*/Exosomes*/Exosomes*/genetics

  • Source: Journal of biomedical science [J Biomed Sci] 2024 Jan 17; Vol. 31 (1), pp. 9. Date of Electronic Publication: 2024 Jan 17.Publisher: BioMed Central Country of Publication: England NLM ID: 9421567 Publication Model: Electronic Cited Medium: Internet ISSN: 1423-0127

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  118,183 results for ""Vaccines""